The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema

被引：0

作者：

Maria Vittoria Cicinelli

Amir Rosenblatt

Domenico Grosso

Piero Zollet

Luigi Capone

Alessandro Rabiolo

Rosangela Lattanzio

Anat Loewenstein

Francesco Bandello

机构：

[1] Vita-Salute San Raffaele University,School of Medicine

[2] IRCCS San Raffaele Scientific Institute,Department of Ophthalmology

[3] Tel-Aviv Sourasky Medical Center,Division of Ophthalmology

[4] Tel-Aviv University,Sackler Faculty of Medicine

[5] Gloucestershire Hospitals NHS Foundation Trust,Department of Ophthalmology

[6] Ophthalmological Unit,Department of Clinical Sciences and Community Health

[7] Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,Department of Medical Retina

[8] University of Milan,Department of Medical Retina

[9] Singapore National Eye Centre,Smt. Kanuri Santhamma Retina Vitreous Centre LV

[10] Singapore Eye Research Institute,Department of Ophthalmology

[11] Duke-NUS Medical School,Service d’ophtalmologie

[12] Aneurin Bevan University Health Board,Kaplan Medical Centre, department of ophthalmology

[13] Prasad Eye Institute,Department of Ophthalmology

[14] University of British Columbia,Department of Retina and Vitreous

[15] hôpital Avicenne DHU Sight Restore,Department of ophthalmology

[16] Affiliated to Hadassah School of medicine,Charité – Universitätsmedizin Berlin

[17] Cantonal Hospital Lucerne,Centre for Vision Research

[18] Moorfields Eye Hospital NHS Foundation Trust,Department of Ophthalmology

[19] UCL Institute of Health Informatics,Department of Ophthalmology

[20] NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology,2nd Department of Ophthalmology

[21] Clínica de Oftalmología de Cali,Department of Ophthalmology

[22] Ophthalmic department Fondazione Policlinico Universitario Agostino Gemelli IRCCS,State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center

[23] Università Cattolica del Sacro Cuore,Department of Ophthalmology

[24] Pitié Salpêtrière University Hospital Sorbonne Université,Department of Ophthalmology

[25] Clínica oftalmológica Santa Lucía,Department of Ophthalmology

[26] corporate member of Freie Universität Berlin Humboldt Universität zu Berlin,undefined

[27] and Berlin Institute of Health,undefined

[28] The Westmead Institute for Medical Research University of Sydney,undefined

[29] Altino Ventura Foundation,undefined

[30] HOPE Eye Hospital,undefined

[31] Attikon Hospital National and Kapodistrian University of Athens,undefined

[32] Faculty of Medicine Siriraj Hospital Mahidol University,undefined

[33] Department of Ophthalmology Puerta de Hierro-Majadahonda University Hospital,undefined

[34] Ocular Microsurgery Institute (IMO),undefined

[35] Sun Yat-sen University,undefined

[36] Yeni Yuzyil University,undefined

[37] Department of Ophthalmology,undefined

[38] Ludwig-Maximilians-University,undefined

[39] National University of Malaysia,undefined

[40] University of Buenos Aires,undefined

来源：

Eye | 2021年 / 35卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3232 / 3242

页数：10

共 50 条

[1] Correction: The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
Maria Vittoria Cicinelli
Amir Rosenblatt
Domenico Grosso
Piero Zollet
Luigi Capone
Alessandro Rabiolo
Rosangela Lattanzio
Anat Loewenstein
Francesco Bandello
Eye, 2021, 35 : 3459 - 3459
[2] The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular edema
Cicinelli, Maria Vittoria
Rosenblatt, Amir
Grosso, Domenico
Zollet, Piero
Capone, Luigi
Rabiolo, Alessandro
Lattanzio, Rosangela
Loewenstein, Anat
Bandello, Francesco
EYE, 2021, 35 (12) : 3232 - 3242
[3] Fluocinolone Acetonide Intravitreal Implant (Iluvien®)In Diabetic Macular Oedema
Mark Sanford
Drugs, 2013, 73 : 187 - 193
[4] Fluocinolone Acetonide Intravitreal Implant (Iluvien®) In Diabetic Macular Oedema
Sanford, Mark
DRUGS, 2013, 73 (02) : 187 - 193
[5] The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema (Jan, 10.1038/s41433-020-01373-1, 2021)
Cicinelli, Maria Vittoria
Rosenblatt, Amir
Grosso, Domenico
Zollet, Piero
Capone, Luigi
Rabiolo, Alessandro
Lattanzio, Rosangela
Loewenstein, Anat
Bandello, Francesco
EYE, 2021, 35 (12) : 3459 - 3459
[6] Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
Massa, Horace
Nagar, Anindyt M.
Vergados, Athanasios
Dadoukis, Panagiotis
Patra, Sudeshna
Panos, Georgios D.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (01) : 31 - 43
[7] Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
Baillif, Stephanie
Staccini, Pascal
Weber, Michel
Delyfer, Marie-Noelle
Le Mer, Yannick
Gualino, Vincent
Collot, Laurence
Merite, Pierre-Yves
Creuzot-Garcher, Catherine
Kodjikian, Laurent
Massin, Pascale
PHARMACEUTICS, 2022, 14 (11)
[8] Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
Messenger, Wyatt B.
Beardsley, Robert M.
Flaxel, Christina J.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 425 - 434
[9] Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
Ciulla, Thomas A.
Harris, Alon
McIntyre, Nathaniel
Jonescu-Cuypers, Christian
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 953 - 959
[10] Fluocinolone acetonide intravitreal implant for diabetic macular oedema: a case report of a patient with a therapy resistant diabetic maculopathy
Kretz, Florian
Auffarth, Gerd
Linz, Katharina
ACTA OPHTHALMOLOGICA, 2014, 92 : 19 - 19

← 1 2 3 4 5 →